chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I accidently got an additional Moderna Covid-19 dose today; Incorrect dosing schedules between 06Apr2022 and 07Jun2022; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Incorrect dosing schedules between 06Apr2022 and 07Jun2022) and EXTRA DOSE ADMINISTERED (I accidently got an additional Moderna Covid-19 dose today) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jun-2022, received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Incorrect dosing schedules between 06Apr2022 and 07Jun2022). On 07-Jun-2022, the patient experienced EXTRA DOSE ADMINISTERED (I accidently got an additional Moderna Covid-19 dose today). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Incorrect dosing schedules between 06Apr2022 and 07Jun2022) and EXTRA DOSE ADMINISTERED (I accidently got an additional Moderna Covid-19 dose today) outcome was unknown.            No concomitant medications were reported. The patient did not have any underlying conditions and was not immunocompromised. The patient received the 3rd dose even though  was not immunocompromised. The patient was given another vaccination on 07Jun2022 at doctor's office.  No treatment medications were reported.   Reporter did not allow further contact
I received the first dose on 12/23/20 and 1/13/21. 1-2 weeks after the first injection, I started to have occasional cardiac arrhythmia but I did not pay attention to. After the second dose, I found I have more frequent cardiac arrhythmia and now it is more frequent. Sometimes I also felt chest pain. As a scientist, I started to think about the possibilities. I think my current heart problem is associated with COVID-19 vaccine. It is possible antibodies raised against the spike protein generated from muscle cells cross-react with a protein in the heart and cause the problem. I am going to visit a family doctor or cardiologist to see what is going on in my heart.
Small circular rash type ash mark on left arm where shot was administered and arthritis type soreness on the same arm.
Increased muscle pain and joint pain all over body....head/neck tics involuntary muscle movement,  jerking of body...hands... taking Advil 200mg 2 tablets dose for pain and monitoring tics as they seem to be starting to subside today...
LEFT ARM AT INJECTION SITE IS SORE, WARM TO TOUCH, SWOLLEN FROM DELTOID MUSCLE DOWN ALMOST TO ELBOW. PATIENT TREATED SELF AT HOME WITH TYLENOL AND ICE FROM 7/15-7/19/22. 7/19/22 ONCE PATIENT CONTACTED OFFICE-PHYSICIAN ADVISED IBUPROFEN AND WARM EPSOM SALT COMPRESSES- FOLLOW UP WITH APPOINTMENT IF NO IMPROVEMENT.
I got my shot on November 7, 2021, and the night of November 16, 2021, my Watch woke me five times telling me that I was in a fib. I continued in a fib without a break for the next five days.  I went to hospital on Sunday, November 21.  They gave me an IV and a chest x-Ray and took blood.  I was there about 8 hours.  They told me to see their on-duty cardiologist, the next morning.   Since then, I have had two more a fib incidents which was short-lived Because I took to Metroprolol and an Eliquis.  I have also had two nights when my pulse was more than 170 for about five hours according to my Watch.
Patient reported "stroke-like" symptoms about 1 hour after getting the 2nd Pfizer vaccine.  She described issues with coordination, weakness in hands, dystonia in her hands.  Numbness L side of her face, lips tingling, eyes felt strange with a burning sensation.  Very mild shortness of breath
I am an RN in the last year of a nurse practioner program and received the vaccine through student health (I think the student health flu vaccine program is closely associated with employee health). Within 24 hours of receiving the vaccine in  my left deltoid I discovered a 2-3cm round, circumscribed, erythemetous, hot, painful, swollen, raised area of skin reaction at the site of administration. It went from 2 to 4 cm over 48 hours and then slowly began to become more diffuse and less red/painful until it diseappeared after 5-6 days. Anectdotally, 4-5 other patients at the time I called employee health had experienced similar symptoms (one had even received antibiotics to treat suspected cellulitis). Additionally, an employee health provider at Hospital told me she's had a couple of patients with this same reaction, which she reported via VAERS. I have never had an allergic reaction to anything before and I was surprised to see this. Just wanted to share my experience for your tracking purposes. Thanks.
Developed hives approximately 5 1/2 hours after vaccine administration, BENADRYL PRN [may be related to bug bites].
The patient developed a 4cm x 7 cm erythema that was warm and slightly tender to touch.
A case of pertussis disease in a two year-old female subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received three doses of PENTACEL, dose one lot number C3683AA received on 01 September 2010, dose two lot number C3713AA received on 12 November 2010 and dose three lot number C3771AA received on 18 January 2011 and one dose of DAPTACEL, lot number C4002BA on 24 January 2012 (routes and sites of administration for all doses not reported). The subject developed cold-like symptoms on 03 June 2013, approximately 16 months after the last dose. On 03 June 2013, the subject developed a cough. The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included positive PCR on 09 June 2013. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 09 June 2013 for three days. The subject was not hospitalized. At the time of final contact on 20 June 2013, the subject's cough was still persisting. The duration of the cough was reported at that time as 17 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Pt recv vax on 12/7/98; on 12/8/98 pt exp angiodema of tongue; tx=Zyrtec, Peparol
Information has been received from a physician concerning a bottle-fed female with chronic acid reflux (gastroesophageal reflux disease) who was vaccinated PO with her second dose of ROTATEQ (no lot# given).  There was no concomitant medication.  Subsequently the patient experienced "stomach pain, gas, cramping and was taking less formula."  The patient sought unspecified medical attention.  Subsequently after about 1 week, the patient recovered.  It was noted that the patient was "switched to another formula called ALIMENTUM."  There was no product quality complaint.  Additional information has been requested.
24 hours after receiving GARDASIL # 1, developed redness and itching both legs (thigh to ankle). Skin became more red with NIVEA. No fever.
Patient received Tdap vaccine 9/24/09.  Significant swelling, pain, and erythema at injection site.  Symptoms did not become less severe after 5 days.  Patient was told these symptoms were due to the preservative in tetanus portion of the Tdap vaccine.
Numbness, tingling of mouth and lips. Patient wnet to ER. Benadryl.
SEVERE REACTIONS; This spontaneous report received from a patient via a company representative concerned 29 patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  "It was reported that, on an unknown date, the patients experienced severe reactions". The action taken with covid-19 vaccine  was not applicable. The outcome of severe reactions was not reported. This report was non-serious.
Burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose; Burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose; Burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose; Burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose; Burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 63-year-old female patient received bnt162b2 (BNT162B2), administration date 15Apr2021 (Lot number: EW0161) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SYNTHROID. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 Immunization. The following information was reported: ORAL DISCOMFORT (non-serious), TONGUE DISCOMFORT (non-serious), THROAT IRRITATION (non-serious), EYE IRRITATION (non-serious), NASAL DISCOMFORT (non-serious) all with onset 15Apr2021, outcome "recovering", and all described as "Burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose". The event "burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose", "burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose", "burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose", "burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose" and "burning in lip; burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose" was evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of oral discomfort, tongue discomfort, throat irritation, eye irritation, nasal discomfort.  Additional information: Patient had the Pfizer vaccine on 4/16 and within less than an hour had kind of burning in lip and then it stayed that way for about 48 hours and then it kind of started burning the tongue, rest of the mouth and then down to the throat all the way even the eyes and the nose. So patient ended up to the doctor office they send her to the ER and they try to treat her with some Benadryl and steroids, they treated her with but patient was still having kind of the same symptoms but not as severe and had been on Zyrtec and Prilosec (treatment).   No follow-up attempts are possible. No further information is expected.
Almost immediately upon receiving the vaccine, he developed a rash of red dots all over his body.  They continued for several days and spread to his face, legs, arms, etc.  At times they would disappear in some areas and new bumps would appear in others.  Some of the bumps were itchy.  It was treated with over-the-counter Benadryl.  After about 1 week, they have mostly disappeared.
substernal chest pain radiating to back, worsening, mild ankle swelling ,   Pain worse with lying down, deep breath,  improves with sitting forward presented to ED admitted to hospital, on  day 12 post vaccination, was hospitalized from november 15, d/c november 17  f/u cardiology on Dec 3,  resting at home with ibuprofen still with pain  improves with ibuprofen
I started getting blurry vision with  calidascope at perifeal vision at least twice per week starting 3 ish weeks after  second dose of fixer vacccine. I have seen and ophthalmologist and had an mri with no other reason for this and my vision is getting a little more blurry each time, and they last about 15 minutes.  I asked Dr. if this could be a result of vaccination and she could not say. I do not believe she reported this.  I have never had this before the second dose of the vaccine? This is still happening.
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A and 002F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information were reported No treatment medications were provided  Date of refrigeration was 19-Aug-2021   This case was linked to MOD-2021-363729, MOD-2021-363032 (Patient Link).
On 3/31/2022, I received my second dose of the Pfizer booster for COVID-19. On 6/21/2022, I began experiencing sore throat, stuffy head, slight fever, and a little bit of coughing. I took an at-home test for COVID-19, and the result was negative. On 6/22/2022, I still had the same symptoms and wasn't feeling well, so I called my doctor's office, and I was referred to an urgent care clinic for a PCR test. On 6/23/2022, I got the result back, and it was positive. The NP who treated me just advised me to watch for difficulty breathing, chest pain, or a fever of over 101. In the meantime, I was just to rest and drink plenty of fluids. He didn't prescribe me any medications. He just told me I could use OTC medications like Claritin, Mucinex, or Delsym to treat the symptoms. I have since then used Claritin and Mucinex, which I have found helpful. I never developed any symptoms other than the abovementioned ones. At the time of this writing, I only have a little bit of a stuffy head and hoarseness (without pain). I have only taken Claritin today; I haven't needed the Mucinex, as my cough has greatly improved.
A sore, raised lump/localized swelling ocurred near the injection site that lasted for 2 1/2 to 3 weeks; A sore, raised lump/localized swelling ocurred near the injection site that lasted for 2 1/2 to 3 weeks; A sore, raised lump/localized swelling ocurred near the injection site that lasted for 2 1/2 to 3 weeks; Information has been received from a nurse practitioner, concerning a female patient of unknown age. The patient's medical history, concurrent conditions, previously drug reactions, allergies and concomitant medications were not provided.  On an unknown date, the patient was vaccinated with the third dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) intramuscularly (anatomical location, lot number and expiration date were not provided) for prophylaxis (reported as vaccination).  Subsequently on an unknown date, a sore, raised, lump localized swelling occurred near the injection site (injection site swelling/injection site lump/injection site pain) that lasted for 2 1/2 to 3 weeks. The outcome of the abovementioned adverse events were unknown at the time of this report.  The causal relationship between the abovementioned adverse events and the therapy with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) was not provided.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient experienced lightheadedness, then passed out for about 20 seconds at around noon on 05/09/2021. Patient has recovered.  Paramedics were called.  Patient refused to go with paramedics.
SORENESS with HUMIRA (ADALIMUMAB); This spontaneous case was reported by a consumer and describes the occurrence of PAIN (SORENESS with HUMIRA (ADALIMUMAB)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PAIN (SORENESS with HUMIRA (ADALIMUMAB)). At the time of the report, PAIN (SORENESS with HUMIRA (ADALIMUMAB)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.  on an unknown date, the patient experienced soreness. covid-19 vaccine was also considered suspect.  It was unknown if patient was enrolled in a covid-19 vaccine trial. on unknown date, patient received 1st dose covid-19 vaccine manufactured by moderna. on an unknown date, patient received 2nd dose covid-19 vaccine manufactured by moderna. primary reporter contact for lot number information was not available.  Causality for humira (adalimumab), the reporter's causality for the event(s) of soreness was not provided.  No treatment information was reported by the reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
two days after initial shot, red and swollen arm at site. 3 days after, cold and flu feeling aches for 1 day, 7 days after itching all over body 20 days later flu feeing aches
felt dizzy following the vaccine, lost consciousness for excess of 4 minutes then was not very responsive for several more minutes.  Called 911 but she refused to go to the hospital.  refused any service from another medical professional and asked to be taken home by her friend.
Patient stated on Day 2-Day 5 after vaccine, she had swelling in her right arm.  She also had headaches and body aches.  She took Motrin and is doing ok now.
Arrhythmia; This is a spontaneous report from a contactable consumer (patient). A 75-year-old male patient received his first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6198), via an unspecified route of administration at arm left on 26Feb2021 10:30 AM at single dose for COVID-19 immunisation. Medical history included heart disorder. Concomitant medications in two weeks included omeprazole (PRILOSEC), lisinopril, nadolol, rosuvastatin calcium (CRESTOR) and aspirin. There was no other vaccine in four weeks, no covid prior vaccination and no covid tested post vaccination. The patient experienced arrhythmia on 28Feb2021 04:00 PM. The patient was hospitalized for arrhythmia for 2 days. Adverse event (AE) was resulted in emergency room/department or urgent care, hospitalization. There was no treatment for event. The outcome of event was not recovered.
About 4 hours after getting the injection she reported pain in her arm , right side of chest, and passed out. She was trying a dress on in a store and a woman was adjusting it and she all of a sudden said mom I don?t feel good I think I?m going to pass out. She reports everything going black. She go so pale almost blue and passed out immediately she started sweating and had a slight rash on her back. EMS was called she was alert before they arrived they checked vitals and all were normal. The rash went away within a day.
Fever, 100.4, chills, body aches, joint aches, headache, extreme tiredness. Lasted from 1:30am , about 12 hours after the 2nd dose and lasted about 36 hours.
Has redness with pimples that started 2-3 weeks later and made a scar on injection site.; Has redness with pimples that started 2-3 weeks later and made a scar on injection site.; Has redness with pimples that started 2-3 weeks later and made a scar on injection site.; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date, dose 2 via an unspecified route of administration on an unspecified date, each as a single dose for as covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the rabies vaccines for rabies.  The patient has redness with pimples that started 2-3 weeks later and made a scar on injection site on an unspecified date with outcome of unknown.  Details were as follows: the patient received two dose series. The patient underwent lab tests and procedures which included antibody test after 25 days and showed negative. The patient had redness with pimples that started 2-3 weeks later and made a scar on injection site. The outcome of has redness with pimples that started 2-3 weeks later and made a scar on injection site was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Covid test result: Positive; Covid test result: Positive; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from product quality group.  A 47 year-old female patient received bnt162b2 (BNT162B2), administration date 09Nov2021 (Lot number: FF2589) at the age of 47 years as dose 3 (booster), single, administration date 18Feb2021 (Lot number: EL3247) as dose 2, single and administration date 28Jan2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 25Feb2022, outcome "unknown" and all described as "Covid test result: Positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (23Feb2022) neg, notes: Neg ag test 23Feb and 24Feb; (24Feb2022) neg, notes: Neg ag test 23Feb and 24Feb; (25Feb2022) positive. It was unknown if therapeutic measures were taken as a result of vaccination failure, covid-19. It was unknown that the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown the patient was diagnosed with COVID-19. Since the vaccination, the patient tested for COVID-19. The patient was exposed at dinner party 17Feb then cough 22Feb then neg ag test 23Feb and 24Feb and positive AG on 25Feb.  No follow-up attempts are possible. No further information is expected.
With a few seconds of the first dose, i felt a little dizziness. The dizziness did not last long. After afew hours i started feeling tired and back pain